CANCER VOICES AUSTRALIA v MYRIAD GENETICS INC  FCA 65:Should gene patent monopolies trump public health?
At a time when the double mastectomy of Angelina Jolie has highlighted the importance of genetic testing for breast cancer, the Federal Court�s decision in Cancer Voices Australia v Myriad Genetics Inc  FCA 65 has clarified that, for now at least, isolated DNA and RNA can constitute a patentable invention under s 18(1)(a) of the Patents Act 1990 (Cth). This is a significant decision for companies seeking to secure patents over DNA and genetic material, whether isolated or not. This column...[Show more]
|Collections||ANU Research Publications|
|Source:||Journal of Law and Medicine|
|01_Vines_CANCER_VOICES_AUSTRALIA_v_2013.pdf||113.33 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.